Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23746

1.

The Cattle Don't Care.

Graff SL.

J Clin Oncol. 2019 Mar 18:JCO1900255. doi: 10.1200/JCO.19.00255. [Epub ahead of print] No abstract available.

PMID:
30883247
2.

Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons Guidelines.

Chang SM, Messersmith H, Ahluwalia M, Andrews D, Brastianos PK, Gaspar LE, Gatson NTN, Jordan JT, Khasraw M, Lassman AB, Maues J, Mrugala M, Raizer J, Schiff D, Stevens G, Sumrall A, van den Bent M, Vogelbaum MA.

J Clin Oncol. 2019 Mar 18:JCO1802085. doi: 10.1200/JCO.18.02085. [Epub ahead of print]

PMID:
30883246
3.

Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance.

Abe T, Blackford AL, Tamura K, Ford M, McCormick P, Chuidian M, Almario JA, Borges M, Lennon AM, Shin EJ, Klein AP, Hruban RH, Canto MI, Goggins M.

J Clin Oncol. 2019 Mar 18:JCO1801512. doi: 10.1200/JCO.18.01512. [Epub ahead of print]

PMID:
30883245
4.

Errata.

[No authors listed]

J Clin Oncol. 2019 Mar 20;37(9):761. doi: 10.1200/JCO.19.00295. No abstract available.

PMID:
30875487
5.

Errata.

[No authors listed]

J Clin Oncol. 2019 Mar 20;37(9):761. doi: 10.1200/JCO.19.00369. No abstract available.

PMID:
30875486
6.

Errata.

[No authors listed]

J Clin Oncol. 2019 Mar 20;37(9):761. doi: 10.1200/JCO.19.00316. No abstract available.

PMID:
30875485
7.

Reply to L. Xie et al.

Mullen EA, Khanna G, Geller JI, Fernandez CV, Dome JS.

J Clin Oncol. 2019 Mar 15:JCO1900012. doi: 10.1200/JCO.19.00012. [Epub ahead of print] No abstract available.

PMID:
30875281
8.

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.

Dieckmann KP, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Haben B, Loidl W, Ruf CG, Heinzelbecker J, Heidenreich A, Cremers JF, Oing C, Hermanns T, Fankhauser CD, Gillessen S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Belge G.

J Clin Oncol. 2019 Mar 15:JCO1801480. doi: 10.1200/JCO.18.01480. [Epub ahead of print]

PMID:
30875280
9.

Clinical Diagnosis Value of Chest X-Ray and Ultrasound in Recurrence in Patients With Favorable-Histology Wilms Tumor.

Xie L, Liu B, Dong K.

J Clin Oncol. 2019 Mar 15:JCO1801886. doi: 10.1200/JCO.18.01886. [Epub ahead of print] No abstract available.

PMID:
30875279
10.

Neratinib Plus Capecitabine Provides a Glimmer of Hope for a Daunting Disease.

Hurvitz SA.

J Clin Oncol. 2019 Mar 15:JCO1900083. doi: 10.1200/JCO.19.00083. [Epub ahead of print] No abstract available.

PMID:
30875278
11.

Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.

Armstrong AJ, Halabi S, Luo J, Nanus DM, Giannakakou P, Szmulewitz RZ, Danila DC, Healy P, Anand M, Rothwell CJ, Rasmussen J, Thornburg B, Berry WR, Wilder RS, Lu C, Chen Y, Silberstein JL, Kemeny G, Galletti G, Somarelli JA, Gupta S, Gregory SG, Scher HI, Dittamore R, Tagawa ST, Antonarakis ES, George DJ.

J Clin Oncol. 2019 Mar 13:JCO1801731. doi: 10.1200/JCO.18.01731. [Epub ahead of print]

PMID:
30865549
12.

Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome.

Innocenti F, Ou FS, Qu X, Zemla TJ, Niedzwiecki D, Tam R, Mahajan S, Goldberg RM, Bertagnolli MM, Blanke CD, Sanoff H, Atkins J, Polite B, Venook AP, Lenz HJ, Kabbarah O.

J Clin Oncol. 2019 Mar 13:JCO1801798. doi: 10.1200/JCO.18.01798. [Epub ahead of print]

PMID:
30865548
13.

Targeting Stroma: A Tale of Caution.

Wang-Gillam A.

J Clin Oncol. 2019 Mar 12:JCO1900056. doi: 10.1200/JCO.19.00056. [Epub ahead of print] No abstract available.

PMID:
30860950
14.

RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database Analysis.

Litière S, Isaac G, De Vries EGE, Bogaerts J, Chen A, Dancey J, Ford R, Gwyther S, Hoekstra O, Huang E, Lin N, Liu Y, Mandrekar S, Schwartz LH, Shankar L, Therasse P, Seymour L; RECIST Working Group.

J Clin Oncol. 2019 Mar 12:JCO1801100. doi: 10.1200/JCO.18.01100. [Epub ahead of print]

PMID:
30860949
15.

Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial.

Rosenthal SA, Hu C, Sartor O, Gomella LG, Amin MB, Purdy J, Michalski JM, Garzotto MG, Pervez N, Balogh AG, Rodrigues GB, Souhami L, Reaume MN, Williams SG, Hannan R, Horwitz EM, Raben A, Peters CA, Feng FY, Shipley WU, Sandler HM.

J Clin Oncol. 2019 Mar 12:JCO1802158. doi: 10.1200/JCO.18.02158. [Epub ahead of print]

PMID:
30860948
16.

Socioeconomic Differences in Referral to Phase I Cancer Clinical Trials: A Danish Matched Cancer Case-Control Study.

Gad KT, Johansen C, Duun-Henriksen AK, Krøyer A, Olsen MH, Lassen U, Mau-Sørensen M, Oksberg Dalton S.

J Clin Oncol. 2019 Mar 12:JCO1801983. doi: 10.1200/JCO.18.01983. [Epub ahead of print]

PMID:
30860947
17.

Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor Study.

Bates JE, Howell RM, Liu Q, Yasui Y, Mulrooney DA, Dhakal S, Smith SA, Leisenring WM, Indelicato DJ, Gibson TM, Armstrong GT, Oeffinger KC, Constine LS.

J Clin Oncol. 2019 Mar 12:JCO1801764. doi: 10.1200/JCO.18.01764. [Epub ahead of print]

PMID:
30860946
18.

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.

Freedman RA, Gelman RS, Anders CK, Melisko ME, Parsons HA, Cropp AM, Silvestri K, Cotter CM, Componeschi KP, Marte JM, Connolly RM, Moy B, Van Poznak CH, Blackwell KL, Puhalla SL, Jankowitz RC, Smith KL, Ibrahim N, Moynihan TJ, O'Sullivan CC, Nangia J, Niravath P, Tung N, Pohlmann PR, Burns R, Rimawi MF, Krop IE, Wolff AC, Winer EP, Lin NU; Translational Breast Cancer Research Consortium.

J Clin Oncol. 2019 Mar 12:JCO1801511. doi: 10.1200/JCO.18.01511. [Epub ahead of print]

PMID:
30860945
19.

In Memoriam: Charles A. Coltman, 1930 to 2018.

Blanke CD, Crowley J, Baker LH, Fisher RI.

J Clin Oncol. 2019 Mar 12:JCO1900270. doi: 10.1200/JCO.19.00270. [Epub ahead of print] No abstract available.

PMID:
30860944
20.

Patient-Centered Preference Assessment to Improve Satisfaction With Care Among Patients With Localized Prostate Cancer: A Randomized Controlled Trial.

Jayadevappa R, Chhatre S, Gallo JJ, Wittink M, Morales KH, Lee DI, Guzzo TJ, Vapiwala N, Wong YN, Newman DK, Van Arsdalen K, Malkowicz SB, Schwartz JS, Wein AJ.

J Clin Oncol. 2019 Mar 12:JCO1801091. doi: 10.1200/JCO.18.01091. [Epub ahead of print]

PMID:
30860943

Supplemental Content

Loading ...
Support Center